Colon Pharmaceuticals announced that the subsidiary's main product, A400 (EP0031), was granted Fast Track Qualification by the US Food and Drug Administration.
科伦药业：子公司主要产品A400 获美国食品药品监督管理局授予快速通道资格认定
Colon Pharmaceuticals: The subsidiary's main product, A400, was granted Fast Track Qualification by the US Food and Drug Administration
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.